✦ LIBER ✦

Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study

✍ Scribed by Toyoda, Hidenori; Kumada, Takashi; Shimada, Noritomo; Takaguchi, Koichi; Ide, Tatsuya; Sata, Michio; Ginba, Hiroyuki; Matsuyama, Kazuhiro; Izumi, Namiki

Book ID: 118763091
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 98 KB
Volume: 85
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.23428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eight-week regimen of antiviral combinat

Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological response

✍ Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Predictive factors of virological non-re

Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the

Mutation frequency of NS5A in patients v

Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy

✍ A. C. W. Jenke; S. Moser; V. Orth; M. Zilbauer; P. Gerner; S. Wirth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Factors associated with rapid and early

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

✍ M. Rodriguez-Torres; M. S. Sulkowski; R. T. Chung; F. M. Hamzeh; D. M. Jensen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Predictive factors of early and sustaine

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

✍ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 136 KB

522 Combination therapy with peginterfer

522 Combination therapy with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB